Survey on Preferences for Tuberculosis Diagnosis at Healthcare Facilities
We invite everyone to participate in the survey “Understanding Preferences for Tuberculosis Diagnosis at Healthcare Facilities to Support the Development of New Tests.” Please note that the survey is available only in English and will take no more than 15 minutes to complete. The goal of the survey is to collect opinions from healthcare professionals, policymakers, researchers, and affected communities
Joint Statement on the Earlier Inclusion of Pregnant Women and Other Individuals in Tuberculosis Research
October 25-28, 2023, Washington, D.C. – Sixteen representatives of communities affected by tuberculosis (TB), with experience in TB during pregnancy, gathered to reach a consensus on the inclusion of pregnant and breastfeeding women and other individuals in TB treatment and vaccine research.
Minutes of the meeting with Hetero, Mylan, Emcure and TB-Alliance
We are glad to present minutes of ECAT meeting with with Hetero, Mylan, Emcure and TB-Alliance which took place in Armenia in October 2019.
Minutes of the meeting of ECAT and Gilead Sciences, Janssen, MSD and ViiV Healthcare
Minutes of the meeting of ECAT and HIV and hepatitis drugs manufacturers are available now. The meeting took place on April, 24-26th, 2019, in St Petersburg, Russia, gathering together more than 30 HIV, hepatitis and TB access to treatment activists from EECA region.